11 Beta-aryl-gona-4, 9-dien-3-ones

1998
OA: closed
AI-generated summary by qwen3.7-flash, 2026-09-20

This patent describes 11 beta-aryl-gona-4,9-dien-3-one compounds as progesterone synthesis inhibitors suitable for treating endometriosis, dysmenorrhea, and endocrine hormone-dependent tumors.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The invention relates to 11 beta -aryl-gona-4,9-dienes of formula I (I) wherein the variables are defined in the specification. The compounds are progesterone synthesis inhibitors and are suitable for inducing labor or an abortion, and for treating endometriosis, dysmenorrhea, and endocrine hormone-dependent tumors.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-07-24T06:18:32.875334+00:00